Article Details
Retrieved on: 2017-12-21 08:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>CytRx logo <b>Vanguard Group</b> Inc. lifted its position in CytRx Co. (NASDAQ:CYTR) by 53.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,823,123 shares of the biotechnology company's stock after buying an additional ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here